Here are the 10-K annual reports from DarioHealth Corp. (DRIO) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow DRIO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DRIO filings page.
DarioHealth Corp. is a vertically integrated digital health company focused on whole-person care for chronic and behavioral conditions. It combines FDA‑cleared hardware, AI built on 13 billion proprietary data points, and coaching to drive behavior change and measurable clinical outcomes across diabetes, hypertension, obesity, musculoskeletal pain, and mental health.
The company serves direct-to-consumer users plus employers, health plans, and pharmaceutical companies through subscription models, often with value-based and risk-sharing contracts. As of its latest disclosure, non-affiliate equity had an aggregate market value of $27,979,487, and there were 7,300,406 shares of common stock outstanding as of March 11, 2026.
DarioHealth highlights more than 100 clinical and real‑world evidence studies supporting A1c reduction, blood pressure and weight improvements, mental health gains, and medical cost savings. It is rolling out AI layers such as DarioIQ for personalized member support and DarioSHIFT to automate internal operations. In September 2025, the board launched a strategic review after multiple unsolicited inbound expressions of interest, considering options including a sale, merger, or continued standalone strategy. In October 2025, DarioHealth also announced a collaboration with OneStep to add smartphone-based gait and fall‑risk assessment to its platform.